{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:05:45Z","timestamp":1792037145451,"version":"4.4.0"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Global Infect Dis"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0974-777x.62887","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T01:59:47Z","timestamp":1273111187000},"page":"167","source":"Crossref","is-referenced-by-count":238,"title":["Drug resistance in leishmaniasis"],"prefix":"10.4103","volume":"2","author":[{"given":"Jaya","family":"Chakravarty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-777X.62887-1","first-page":"267","volume-title":"Human leishmaniases: epidemiology and public health aspects","author":"Desjeux","year":"1992","journal-title":"World Health Stat Q"},{"key":"key-10.4103\/0974-777X.62887-2","first-page":"62","volume-title":"Epidemiology of visceral leishmaniasis in India","author":"Bora","year":"1999","journal-title":"Natl Med J India"},{"key":"key-10.4103\/0974-777X.62887-3","first-page":"12","volume-title":"Genital manifestations of tropical diseases","author":"Richens","year":"2004","journal-title":"Sex Transm Infect"},{"key":"key-10.4103\/0974-777X.62887-4","first-page":"505","volume-title":"Epidemiology of the leishmaniases","author":"Magill","year":"1995","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/0974-777X.62887-5","first-page":"298","volume-title":"Leishmania and human immunodeficiency virus coinfection: the first 10 years","author":"Alvar","year":"1997","journal-title":"Clin Microbiol Rev"},{"key":"key-10.4103\/0974-777X.62887-6","first-page":"3","volume-title":"LeishmaniaIHIV co-infections: epidemiology in Europe","author":"Desjeux","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"key-10.4103\/0974-777X.62887-7","first-page":"464","volume-title":"Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study","author":"Laguna","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.62887-8","first-page":"133","volume-title":"Visceral leishmaniasis in HIV infected patients: treatment with high dose liposomal amphotericin B (AmBisome)","author":"Russo","year":"1996","journal-title":"J Infect"},{"key":"key-10.4103\/0974-777X.62887-9","first-page":"541","volume-title":"AIDS and Leishmania infantum.New approaches for a new epidemiological problem","author":"Alvar","year":"1996","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/0974-777X.62887-10","first-page":"29","volume-title":"HIV and the transmission of Leishmania","author":"Molina","year":"2003","journal-title":"Ann Trop Med Parasitol"},{"key":"key-10.4103\/0974-777X.62887-11","first-page":"5","volume-title":"Childhood Mediterranean visceral leishmaniasis","author":"Cascio","year":"2003","journal-title":"Infez Med"},{"key":"key-10.4103\/0974-777X.62887-12","first-page":"75","volume-title":"Liposomal amphotericin B (AmBisome) in Mediterranean visceral leishmaniasis: a multicentre trial","author":"Davidson","year":"1994","journal-title":"Q J Med"},{"key":"key-10.4103\/0974-777X.62887-13","first-page":"353","volume-title":"Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran","author":"Asilian","year":"2003","journal-title":"Bull World Health Organ"},{"key":"key-10.4103\/0974-777X.62887-14","first-page":"227","volume-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study","author":"el-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-777X.62887-15","first-page":"1575","volume-title":"Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis","author":"Firooz","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/0974-777X.62887-16","first-page":"1266","volume-title":"Miltefosine for new world cutaneous leishmaniasis","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-17","first-page":"320","volume-title":"Drug responsiveness in experimental cutaneous leishmaniosis","author":"Ercoli","year":"1966","journal-title":"Exp Parasitol"},{"key":"key-10.4103\/0974-777X.62887-18","first-page":"1921","volume-title":"HIV viral load and response to antileishmanial chemotherapy in co-infected patients","author":"Berhe","year":"1999","journal-title":"AIDS"},{"key":"key-10.4103\/0974-777X.62887-19","doi-asserted-by":"crossref","unstructured":"Carson PE. 8-aminoquinolines, In: Peters W, Richards WH, editors. Antimalarial drugs II. Berlin, Germany: Springer-Verlag; 1984. p. 83-121.","DOI":"10.1007\/978-3-642-69254-3_3"},{"key":"key-10.4103\/0974-777X.62887-20","first-page":"S42","volume-title":"Pharmacokinetics and pharmacology of terbinafine and itraconazole","author":"Leyden","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-777X.62887-21","first-page":"113","volume-title":"Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis","author":"Al-Jaser","year":"1995","journal-title":"Pharm Res"},{"key":"key-10.4103\/0974-777X.62887-22","doi-asserted-by":"crossref","unstructured":"Allen S, Neal RA. The in vitro susceptibility of macrophages infected with amastigotes of Leishmania spp. to pentavalent antimonial drugs and other compounds with special relevance to cutaneous isolates. In: Hart DT, editor. Leishmaniasis. New York, NY: Plenum Press; 1998, p.711-20.","DOI":"10.1007\/978-1-4613-1575-9_88"},{"key":"key-10.4103\/0974-777X.62887-23","first-page":"566","volume-title":"Activity of imidazoles against Leishmania tropica in human macrophage cultures","author":"Berman","year":"1981","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-24","first-page":"577","volume-title":"The sensitivity of Leishmania species to aminosidine","author":"Neal","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.62887-25","first-page":"528","volume-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","author":"Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-26","first-page":"1","volume-title":"The treatment of kala-azar.New approach to an old problem","author":"Peters","year":"1981","journal-title":"Indian J Med Res"},{"key":"key-10.4103\/0974-777X.62887-27","first-page":"563","volume-title":"Clinical profile of cases of kala-azar in Bihar","author":"Aikat","year":"1979","journal-title":"Indian J Med Res"},{"key":"key-10.4103\/0974-777X.62887-28","first-page":"895","volume-title":"Comparison of regimens of treatment with sodium stibogluconate in kala-azar","author":"Thakur","year":"1984","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key-10.4103\/0974-777X.62887-29","first-page":"1557","volume-title":"Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study","author":"Thakur","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"key-10.4103\/0974-777X.62887-30","first-page":"103","volume-title":"Evaluation of efficacy of longer durations of therapy of fresh cases of kala-azar with sodium stibogluconate","author":"Thakur","year":"1991","journal-title":"Indian J Med Res"},{"key":"key-10.4103\/0974-777X.62887-31","first-page":"868","volume-title":"Therapeutic use of sodium stibogluconate in kala-azar from some hyperendemic districts of N.Bihar, India","author":"Jha","year":"1992","journal-title":"(Abstract) J Assoc Physicians India"},{"key":"key-10.4103\/0974-777X.62887-32","first-page":"1104","volume-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-33","first-page":"1117","volume-title":"Response to interferon-\u03ac plus pentavalent antimony in Indian visceral leishmaniasis","author":"Sundar","year":"1997","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-34","first-page":"350","volume-title":"Treatment of visceral leishmaniasis in south-eastern Nepal: decreasing efficacy of sodium stibogluconate and need for a policy to limit further decline","author":"Rijal","year":"2003","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-35","first-page":"564","volume-title":"Evidence that the high incidence of treatment failures in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani","author":"Lira","year":"1999","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-36","first-page":"307","volume-title":"Clinico-epidemiological study of drug resistance in Indian kala-azar","author":"Sundar","year":"1994","journal-title":"BMJ"},{"key":"key-10.4103\/0974-777X.62887-37","first-page":"139","volume-title":"A cluster of cases of severe cardiotoxicity among kala-azar patients treated with a high-osmolarity lot of sodium antimony gluconate","author":"Sundar","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-38","first-page":"464","volume-title":"Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study","author":"Laguna","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.62887-39","first-page":"459","volume-title":"Susceptibility of clinically sensitive and resistant Leishmania to pentavalent anti-mony in vitro","author":"Berman","year":"1982","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-40","doi-asserted-by":"crossref","unstructured":"Bryceson AD, Chulay JD, Ho M, Mugambii M, Were JB, Muigai R, et al. Visceral leishmaniasis unresponsive to antimonial drugs. 1. Clinical and immunological studies. Trans R Soc Trop Med Hyg 1985;79:700-4.","DOI":"10.1016\/0035-9203(85)90197-X"},{"key":"key-10.4103\/0974-777X.62887-41","first-page":"827","volume-title":"In vitro and in vivo resistance of Leishmania infantum to meglumine antimoniate: a study of 37 strains collected from patients with visceral leishmaniasis","author":"Faraut-Gambarelli","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-42","first-page":"695","volume-title":"Metabolism and functions of trypanothione in the Kinetoplastida","author":"Fairlamb","year":"1992","journal-title":"Annu Rev Microbiol"},{"key":"key-10.4103\/0974-777X.62887-43","first-page":"13186","volume-title":"A trypanothione-dependent glyoxalase I with a prokaryotic ancestry in Leishmania major","author":"Vickers","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.4103\/0974-777X.62887-44","first-page":"913","volume-title":"Glutathione-induced conversion of pentavalent antimony to trivalent antimony in meglumine antimoniate","author":"Frezard","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-45","first-page":"3971","volume-title":"Novel intracellular Sb-V reducing activity correlates with antimony susceptibility in Leishmania donovani","author":"Shaked-Mishan","year":"2001","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-46","first-page":"39925","volume-title":"Dual action of antimonial drugs on thiol redox metabolism in the human pathogen Leishmania donovani","author":"Wyllie","year":"2004","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-47","first-page":"2064","volume-title":"Antimonial-mediated DNA fragmentation in Leishmania infantum amastigotes","author":"Sereno","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-48","first-page":"25120","volume-title":"Antimonial-induced increase in intracellular Ca 2+ through non-selective cation channels in the host and the parasite is responsible for apoptosis of intracellular Leishmania donovani amastigotes","author":"Sudhandiran","year":"2003","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-49","first-page":"87","volume-title":"Cytochrome C-mediated apoptosis","author":"Jiang","year":"2004","journal-title":"Annu Rev Biochem"},{"key":"key-10.4103\/0974-777X.62887-50","first-page":"3971","volume-title":"Novel Intracellular SbV reducing activity correlates with antimony susceptibility in Leishmania donovani","author":"Shaked-Mishan","year":"2001","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-51","first-page":"37445","volume-title":"Leishmania major LmACR2 is a pen-tavalent antimony reductase that confers sensitivity to the drug Pentostam","author":"Zhou","year":"2004","journal-title":"J BioI Chern"},{"key":"key-10.4103\/0974-777X.62887-52","first-page":"405","volume-title":"Reduction of anti-leishmanial pentavalent antimonial drugs by a parasite-specific thiol-dependent reductase, TDRI","author":"Denton","year":"2004","journal-title":"Biochem J"},{"key":"key-10.4103\/0974-777X.62887-53","first-page":"31010","volume-title":"Drug uptake and modulation of drug resistance in Leishmania by an aquaglyceroporin","author":"Gourbal","year":"2004","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-54","first-page":"10383","volume-title":"Trypanothione overproduction and resistance to antimonials and arsenicals in Leishmania","author":"Mukhopadhyay","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"key-10.4103\/0974-777X.62887-55","first-page":"3057","volume-title":"Co-amplification of the gamma-glutamylcysteine synthetase gene gsh1 and of the ABC transporter gene pgpA in arsenite-resistant Leishmania tarentolae","author":"Grondin","year":"1997","journal-title":"EMBO J"},{"key":"key-10.4103\/0974-777X.62887-56","first-page":"726","volume-title":"Elevated levels of polyamines and trypanothione resulting from overexpression of the ornithine decarboxylase gene in arsenite-resistant Leishmania","author":"Haimeur","year":"1999","journal-title":"Mol Microbiol"},{"key":"key-10.4103\/0974-777X.62887-57","first-page":"43","volume-title":"ABC transporters in Leishmania and their role in drug resistance","author":"Ouellette","year":"1998","journal-title":"Drug Resist Updat"},{"key":"key-10.4103\/0974-777X.62887-58","first-page":"67","volume-title":"ABC transporters: from microorganisms to man","author":"Higgins","year":"1992","journal-title":"Annu Rev Cell Bioi"},{"key":"key-10.4103\/0974-777X.62887-59","first-page":"18427","volume-title":"Heavy metal resistance: a new role for P-glycoproteins in Leishmania","author":"Callahan","year":"1991","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-60","first-page":"737","volume-title":"Drug resistance and P-glycoprotein gene amplification in the protozoan parasite Leishmania","author":"Ouellette","year":"1991","journal-title":"Res Microbiol"},{"key":"key-10.4103\/0974-777X.62887-61","first-page":"26301","volume-title":"The Leishmania ATP-binding cassette protein PGPA is an intracellular metal-thiol transporter ATPase","author":"Legare","year":"2001","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-62","first-page":"1988","volume-title":"Role of the ABC transporter MRPA (PGPA) in antimony resistance in Leishmania infantum axenic and intracellular amastigotes","author":"El","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-63","first-page":"600","volume-title":"Novel mechanism of drug resistance in kala azar field isolates","author":"Singh","year":"2003","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-64","first-page":"314","volume-title":"Changing response to diamidine compounds in cases of kala-azar unresponsive to antimonial","author":"Jha","year":"1991","journal-title":"J Assoc Physicians India"},{"key":"key-10.4103\/0974-777X.62887-65","first-page":"167","volume-title":"Evaluation of diamidine compound (pentamidine isethionate) in the treatment resistant cases of kala-azar occurring in North Bihar, India","author":"Jha","year":"1983","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-66","first-page":"331","volume-title":"Influence of clinical presentation on the efficacy of a short course of pentamidine in the treatment of cutaneous leishmaniasis in French Guiana","author":"Nacher","year":"2001","journal-title":"Ann Trop Med Parasitol"},{"key":"key-10.4103\/0974-777X.62887-67","first-page":"107","volume-title":"Successful treatment of Colombian cutaneous leishmaniasis with four injections of pen-tamidine","author":"Soto","year":"1 Tr","journal-title":"Am"},{"key":"key-10.4103\/0974-777X.62887-68","first-page":"447","volume-title":"Comparative study of meglumine antimoniate, pentamidine isethionate and amino-sidine sulfate in the treatment of primary skin lesions caused by Leishmania (Viannia) braziliensis","author":"Correia","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"key":"key-10.4103\/0974-777X.62887-69","first-page":"365","volume-title":"A com-parative study between the efficacy of pentamidine isothionate given in three doses for one week and N-methil-glucamine in a dose of 20 mg Sb V\/day for 20 days to treat cutaneous leishmania-sis","author":"de","year":"2003","journal-title":"Rev Soc Bras Med Trop"},{"key":"key-10.4103\/0974-777X.62887-70","first-page":"492","volume-title":"Treatment of mucocutaneous leishmaniasis with pentamidine isothionate","author":"Amato","year":"1998","journal-title":"Ann Dermatol Venereol"},{"key":"key-10.4103\/0974-777X.62887-71","first-page":"232","volume-title":"Pentamidine uptake and resistance in pathogenic protozoa: past, present and future","author":"Bray","year":"2003","journal-title":"Trends Parasitol"},{"key":"key-10.4103\/0974-777X.62887-72","first-page":"3731","volume-title":"Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion","author":"Basselin","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-73","first-page":"83","volume-title":"Functional genetic identification of PRP1, an ABC transporter superfamily member conferring pentamidine resistance in Leishmania major","author":"Coelho","year":"2003","journal-title":"Mol Biochem Parasitol"},{"key":"key-10.4103\/0974-777X.62887-74","first-page":"9","volume-title":"Amphotericin B deoxycholate treatment of visceral leishmaniasis with newer modes of administration and precautions: a study of 938 cases","author":"Thakur","year":"1999","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-75","first-page":"1256","volume-title":"Amphotericin versus pentamidine in antimony-unresponsive kala-azar","author":"Mishra","year":"1992","journal-title":"Lancet"},{"key":"key-10.4103\/0974-777X.62887-76","first-page":"133","volume-title":"Short-course, low-dose amphotericin B lipid complex therapy for visceral leishmaniasis unresponsive to antimony","author":"Sundar","year":"1997","journal-title":"Ann Intern Med"},{"key":"key-10.4103\/0974-777X.62887-77","first-page":"143","volume-title":"Low-dose liposomal amphotericin B in refractory Indian visceral leishmaniasis: a multicenter study","author":"Sundar","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-78","first-page":"49","volume-title":"DS Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis","author":"Berman","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-79","first-page":"25","volume-title":"Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries","author":"Berman","year":"1998","journal-title":"Bull World Health Organ"},{"key":"key-10.4103\/0974-777X.62887-80","first-page":"352","volume-title":"Mechanism of amphotericin B resistance in Leishmania donovani promastigotes","author":"Mbongo","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-81","first-page":"2409","volume-title":"Cloning of S-adenosyl-L-methionine:C-24-\u2206-sterolmethyltransferase (ERG6) from Leishmania donovani and characterization of mRNAs in wild-type and amphotericin B-resistant promastigotes","author":"Pourshafie","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-82","first-page":"2141","volume-title":"Leishmania infantum: lack of parasite resistance to amphotericin B in a clinically resistant visceral leishmaniasis","author":"Durand","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-83","first-page":"71","volume-title":"Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantum isolates from patients with visceral leishmaniasis","author":"Di","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.62887-84","first-page":"1110","volume-title":"Short-course miltefosine treatment for visceral leishmaniasis","author":"Sundar","year":"2000","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-85","first-page":"928","volume-title":"A policy for leishmaniasis with respect to the prevention and control of drug resistance","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"key":"key-10.4103\/0974-777X.62887-86","first-page":"151","volume-title":"Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B","author":"Escobar","year":"2002","journal-title":"Acta Trop"},{"key":"key-10.4103\/0974-777X.62887-87","first-page":"272","volume-title":"The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine","author":"Yardley","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-88","first-page":"1266","volume-title":"Miltefosine for new world cutaneous leishmaniasis","author":"Soto","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-89","first-page":"3010","volume-title":"Possible mechanism of miltefosinemediated death of Leishmania donovani","author":"Verma","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-90","first-page":"852","volume-title":"Miltefosine induces apoptosis-like death in Leishmania donovani promastigotes","author":"Paris","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-91","first-page":"2397","volume-title":"Resistance to miltefosine in Leishmania donovani involves a defective inward translocation of the drug","author":"P\u0384erez-Victoria","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key-10.4103\/0974-777X.62887-92","first-page":"49965","volume-title":"Functional cloning of the miltefosine transporter.A novel P-type phospholipid translocase from Leishmania involved in drug resistance","author":"Perez-Victoria","year":"2003","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-93","first-page":"23766","volume-title":"Phospholipid translocation and miltefosine potency require both L.donovani miltefosine transporter and the new protein LdRos3 in Leishmania parasites","author":"P\u03b9rez-Victoria","year":"2006","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0974-777X.62887-94","first-page":"311","volume-title":"Multidrug resistance phenotype mediated by the P-glycoprotein-like transporter in Leishmania: a search for reversal agents","author":"Perez-Victoria","year":"2002","journal-title":"Curr Drug Targets"},{"key":"key-10.4103\/0974-777X.62887-95","first-page":"380","volume-title":"Characterization of Leishmania donovani promastigotes resistant to hexadecylphophocholine (miltefosine)","author":"Seifert","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0974-777X.62887-96","first-page":"2571","volume-title":"Injectable paromomycin for visceral leishmaniasis in India","author":"Sundar","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-777X.62887-97","first-page":"227","volume-title":"Topical treatment of Old World cutaneous leishmaniasis caused by Leishmania major: a double-blind control study","author":"el-On","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/0974-777X.62887-98","first-page":"92","volume-title":"Topical treatment of American cutaneous leishmaniasis with paramomycin and methylbenzethonium chlo-ride: a clinical study under field conditions in Ecuador","author":"Krause","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-99","first-page":"734","volume-title":"Topical treatment of New and OldWorld cutaneous leishmaniasis in experimental animals","author":"el-On","year":"1987","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-100","first-page":"577","volume-title":"The sensitivity of Leishmania species to aminosidine","author":"Neal","year":"1995","journal-title":"J Antimicrob Chemother"},{"key":"key-10.4103\/0974-777X.62887-101","first-page":"334","volume-title":"Aminosidine and its combination with sodium stibogluconate in the treatment of diffuse cutaneous leishmaniasis caused byLeishmania aethiopica","author":"Teklemariam","year":"1994","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-102","first-page":"339","volume-title":"In vivo interference of paromomycin with mitochondrial activity of Leishmania","author":"Maarouf","year":"1997","journal-title":"Exp Cell Res"},{"key":"key-10.4103\/0974-777X.62887-103","first-page":"421","volume-title":"Ribosomes of Leishmania are a target for the aminoglycosides","author":"Maarouf","year":"1995","journal-title":"Parasitol Res"},{"key":"key-10.4103\/0974-777X.62887-104","first-page":"167","volume-title":"Development and characterization of paromomycin-resistant Leishmania donovani promastigotes","author":"Maarouf","year":"1998","journal-title":"Parasite"},{"key":"key-10.4103\/0974-777X.62887-105","doi-asserted-by":"crossref","unstructured":"Jhingram A, Chawla B, Saxena S, Barrett MP, Madhubala R. Paromomycin: uptake and resistance in Leishmania donovani. Mol Biochem Parasitol 2009;164:111-7.","DOI":"10.1016\/j.molbiopara.2008.12.007"},{"key":"key-10.4103\/0974-777X.62887-106","first-page":"685","volume-title":"Phase 2 trial of WR6026 an orally administered 8-aminoquinoline, in the treatment of visceral leishmaniasis caused by Leishmania chagasi","author":"Dietze","year":"2001","journal-title":"Am J Trop Med Hyg"},{"key":"key-10.4103\/0974-777X.62887-107","first-page":"319","volume-title":"Chemotherapy of leishmaniasis","author":"Croft","year":"2002","journal-title":"CUIT Pharm Des"},{"key":"key-10.4103\/0974-777X.62887-108","first-page":"528","volume-title":"Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala","author":"Navin","year":"1992","journal-title":"J Infect Dis"},{"key":"key-10.4103\/0974-777X.62887-109","first-page":"394","volume-title":"Availability of miltefosine for the treatment of kala-azar in India","author":"Sundar","year":"2005","journal-title":"Bull World Health Organ"},{"key":"key-10.4103\/0974-777X.62887-110","first-page":"1000","volume-title":"New treatment approach in indian visceral leishmaniasis: single-dose liposomal amphotericin b followed by short-course oral miltefosine","author":"Sundar","year":"2008","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Global Infectious Diseases"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:51:13Z","timestamp":1786632673000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-777X.62887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010]]}},"alternative-id":["62887"],"URL":"https:\/\/doi.org\/10.4103\/0974-777x.62887","relation":{},"ISSN":["0974-777X"],"issn-type":[{"value":"0974-777X","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}